Rescheduling May Drive Sentiment In 2026 But Fundamentals Will Drive Performance

Photo by Rick Proctor on Unsplash

As we approach the end of the first quarter of 2026, the cannabis industry finds itself at an important inflection point – one defined by the growing likelihood of a significant federal catalyst, but not yet by a corresponding shift in operating fundamentals.

Rescheduling remains the most consequential potential development on the horizon. A move to Schedule III would represent meaningful progress for the industry, particularly through the eventual elimination of 280E. It would remove a long-standing structural burden and signal increased federal alignment with the realities of state-regulated markets.

But it is important to distinguish between catalyst and impact.

If rescheduling is finalized in 2026, it will likely serve as a powerful driver of sentiment, improving investor perception, increasing engagement from capital markets participants, and reducing a key element of regulatory uncertainty. What it will not do, at least in the near term, is materially change business performance within the same year.

Operators will still navigate 2026 under largely the same conditions that defined 2025. Section 280E remains in place today. Banking reform has not yet been enacted. Competitive dynamics within mature markets such as pricing pressure, consumer value orientation, and elevated operating costs, continue to shape day-to-day performance.

Even with rescheduling, the financial benefits are more likely to be realized in future periods. Improved tax treatment will enhance after-tax cash flow over time, but it will not immediately reset margins, transform balance sheets, or alter the underlying economics of cultivation and retail operations in the current year.

That distinction matters because the industry has already undergone a meaningful reset.

Over the past several years, operators have worked through a period of normalization, adjusting to competitive supply conditions, rationalizing costs, refining SKU strategies, and, in many cases, restructuring their capital bases. The businesses that remain have done so by adapting to a more disciplined and demanding operating environment.

The market today reflects that evolution. Wholesale pricing in established states has stabilized at competitive levels. Consumers remain price sensitive. Input costs, including labor, utilities, and compliance, remain elevated. Access to capital exists, but on far more selective and rigorous terms than in earlier phases of the industry’s growth.

In that context, waiting for reform is not a strategy. Execution is.

When 280E is eliminated, the benefits to compliant operators will be real. Greater after-tax cash flow can support reinvestment, deleveraging, and improved liquidity. But those benefits should be viewed as an accelerant to well-run businesses – not a remedy for structural inefficiencies, oversized footprints, or capital strategies built for a different market environment.

What will define the remainder of 2026 is alignment with current realities. That includes calibrating cultivation capacity to actual demand, maintaining disciplined inventory management, optimizing labor productivity, and prioritizing return on invested capital over expansion for its own sake. All of which we are seeing across the landscape.

Liquidity, in particular, remains central. In a capital-constrained environment, liquidity is an operating discipline. It informs decisions across the business, from procurement and inventory to growth pacing and capital allocation. Operators that preserve flexibility will be better positioned regardless of the timing of federal action.

There are also incremental developments that may shape the competitive landscape. Increased scrutiny of intoxicating hemp-derived products could, over time, reduce certain forms of regulatory arbitrage and modestly improve pricing stability in regulated markets. These changes are likely to be gradual, but they reinforce the value of compliance and operational consistency.

The broader transition underway in cannabis is one of maturation. The industry has moved beyond its early expansion phase into one defined by discipline, efficiency, and repeatable execution.

Against that backdrop, 2026 may ultimately be remembered as a pivotal year, not because of an immediate transformation in operating performance, but because it marked the emergence of a credible federal catalyst.

Rescheduling, when achieved, will remove a significant overhang and set the stage for improved economics in the years ahead. But it will not replace the need for operational rigor.

The opportunity for operators today is clear: continue to build resilient, efficient businesses that perform under current conditions and be positioned to benefit when structural tailwinds arrive.